TC
IONS icon

Truvestments Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Truvestments Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56 Hold
1
– – ﹤0.01% 1142
2025
Q4 		$59 Hold
1
– – ﹤0.01% 997
2025
Q3 		$49 Hold
1
– – ﹤0.01% 1008
2025
Q2 		$30 Sell
1
-39
-98% -$1.28K ﹤0.01% 948
2025
Q1 		$1.21K Buy
+40
New +$1.31K ﹤0.01% 919
2019
Q3 		– Sell
-102
Closed -$7K – 704
2019
Q2 		$7K Buy
+102
New +$7.21K ﹤0.01% 573

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Truvestments Capital's IONS Position: Q1 2026 in Review

Truvestments Capital held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 1 share worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Truvestments Capital first reported a position in IONS in Q2 2019 and has held it in 6 quarters since. The position peaked at $7K in Q2 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Truvestments Capital held 1 share of Ionis Pharmaceuticals worth $56 as of Q1 2026.
  • Truvestments Capital left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #1142 holding.
  • Truvestments Capital first reported a position in Ionis Pharmaceuticals in Q2 2019 and has held it in 6 quarters since.
  • Truvestments Capital's Ionis Pharmaceuticals position peaked at $7K in Q2 2019.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.